Zurich Cantonal Bank
IMNM icon

Zurich Cantonal Bank’s Immunome IMNM Stock Holding History

Zurich Cantonal Bank’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,431
Closed -$761K – 3015
2025
Q4 		$761K Buy
+35,431
New +$622K ﹤0.01% 1518

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Zurich Cantonal Bank's IMNM Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Immunome (IMNM) in Q1 2026: 44,488 shares worth $973K. The stake represents ﹤0.01% of the portfolio and ranks #1450 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in IMNM as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in IMNM in Q2 2024 and has held it in 7 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Zurich Cantonal Bank held 44,488 shares of Immunome worth $973K as of Q1 2026.
  • Immunome was a new Zurich Cantonal Bank position in Q1 2026.
  • Immunome made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1450 holding.
  • Zurich Cantonal Bank first reported a position in Immunome in Q2 2024 and has held it in 7 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.